Kitamura Yohei, Sasaki Hikaru, Yoshida Kazunari
Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Brain Tumor Pathol. 2017 Apr;34(2):78-90. doi: 10.1007/s10014-017-0283-y. Epub 2017 Apr 21.
Chordomas and chondrosarcomas are two major malignant bone neoplasms located at the skull base. These tumors are rarely metastatic, but can be locally invasive and resistant to conventional chemotherapies and radiotherapies. Accordingly, therapeutic approaches for the treatment of these tumors can be difficult. Additionally, their location at the skull base makes them problematic. Although accurate diagnosis of these tumors is important because of their distinct prognoses, distinguishing between these tumor types is difficult due to overlapping radiological and histopathological findings. However, recent accumulation of molecular and genetic studies, including extracranial location analysis, has provided us clues for accurate diagnosis. In this report, we review the genetic aberrations and molecular biology of these two tumor types. Among the abundant genetic features of these tumors, brachyury immunohistochemistry and direct sequencing of IDH1/2 are simple and useful techniques that can be used to distinguish between these tumors. Although it is still unclear why these tumors, which have such distinct genetic backgrounds, show similar histopathological findings, comparison of their genetic backgrounds could provide essential information.
脊索瘤和软骨肉瘤是位于颅底的两种主要恶性骨肿瘤。这些肿瘤很少发生转移,但可能具有局部侵袭性,并且对传统化疗和放疗具有抗性。因此,治疗这些肿瘤的方法可能具有挑战性。此外,它们位于颅底也带来了问题。尽管由于这些肿瘤预后不同,准确诊断很重要,但由于放射学和组织病理学表现重叠,区分这些肿瘤类型很困难。然而,包括颅外定位分析在内的分子和遗传学研究的最新积累为我们提供了准确诊断的线索。在本报告中,我们回顾了这两种肿瘤类型的基因畸变和分子生物学。在这些肿瘤丰富的基因特征中,brachyury免疫组织化学和IDH1/2直接测序是可用于区分这些肿瘤的简单且有用的技术。尽管目前仍不清楚为什么这些具有如此不同基因背景的肿瘤会表现出相似的组织病理学表现,但比较它们的基因背景可能会提供重要信息。